Tag - RMTI

 Rockwell Medical Technology (Nasdaq:RMTI), VSE Corp (Nasdaq:VSEC), Isramco Inc (Nasdaq:ISRL) and Kewaynee Scientific Corp (Nasdaq:KEQU) are among the biggest percentage losers in Friday's trading among companies with market capitalizations under $1 billion.

Rockwell Medical Technologies, Inc. (Nasdaq: RMTI), a manufacturer and developer of renal drug therapies and essential dialysate products, reported today that the FDA has approved initiation of a National Institutes of Health (NIH) sponsored clinical study for its proprietary drug-delivery product SFP for chronic hemodialysis patients.

SFP is a water soluble form of iron designed to provide physiological-iron-maintenance-therapy for anemic ESRD patients

Shares of Rockwell Medical (RMTI) were halted in pre-market trading.

AeroCentury Corp. (AMEX: ACY) shares are down after two of the company’s directors reported in SEC filings today and Wednesday that they disposed of 770 shares.

Arrowhead Research Corp. (Nasdaq: ARWR) shares are down more than 5% after the biotech company announced Friday morning that interim Phase I data had been published on its anti-cancer drug IT-101. The data was published in the 2007 American Society for Clinical Oncology Proceedings. In the article, the authors wrote that “the stable disease rate, although not yet conclusive, is consistent with promising efficacy.”

These are the biggest percentage losers in Friday's trading among companies with market capitalizations under $500 million: